GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm	Active, not recruiting	Not stated	2024-10-31		NCT05674422

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Grupo Espanol Multidisciplinario del Cancer Digestivo	2

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
H. de la Santa Creu I Sant Pau	Barcelona	Spain	2
H. Univeristario La Paz	Madrid	Spain	1
H.U. Vall d'Hebron	Barcelona	Spain	2
Hospital Clínic, Universitat de Barcelona	Barcelona	Spain	1
Hospital Clínico Universitario Lozano Blesa	Zaragoza	Spain	11
Hospital Del Mar, Barcelona	Barcelona	Spain	1
Hospital Germans Trias i Pujol - ICO Badalona	Badalona	Spain	1
Hospital Quirón Salud Valencia	Valencia	Spain	1
Hospital Sant Joan Despí - Moisés Broggi.	Barcelona	Spain	1
Hospital Universitari i Politècnic La Fe	Valencia	Spain	19
Hospital Universitari Mutua de Terrassa	Terrassa	Spain	1
Hospital Universitario 12 de Octubre	Madrid	Spain	55
Hospital Universitario Miguel Servet	Zaragoza	Spain	27
ICO Girona	Girona	Spain	3
ICO-Hospitalet	Barcelona	Spain	1